A minor earthquake rattled southern Illinois early Monday morning, according to data from the U.S. Geological Survey. The tremor struck at approximately 2:05 a.m. local time, bringing a brief moment of sudden motion to residents across Edwards County and the surrounding region without causing any immediate reports of structural damage or injuries.
Locating the Tremor Near West Salem and Edwards County
Seismologists pinpointed the epicenter roughly six kilometers northeast of West Salem in Edwards County. The seismic event registered at a preliminary magnitude of 3.5 on the Richter scale, originating at a depth of 19.1 kilometers beneath the surface.
Wabash Valley Seismic Zone Versus New Madrid Activity
Most everyday conversations about Midwestern earthquakes immediately turn toward the notorious New Madrid Seismic Zone, situated down in the central Mississippi River valley. That massive fault network has generated more than 3,000 recorded earthquakes since 1974, according to state emergency management authorities. Yet Monday’s event highlights a different geological neighbor entirely: the Wabash Valley Seismic Zone.
Straddling portions of southeastern Illinois and southwestern Indiana, the Wabash Valley zone operates under a slightly different rhythm. While New Madrid steals the headlines for frequency, the Wabash Valley holds the modern record for sheer muscle power in the Land of Lincoln. On April 18, 2008, a robust 5.4-magnitude earthquake struck Mount Carmel, Illinois, leaving behind cracked plaster and shaken nerves across multiple states.
A Quiet Year for Illinois Seismology
Monday’s morning rumble fits into a relatively sparse catalog of seismic events recorded across Illinois so far. Prior to this event, the state’s most notable recent tremor occurred in January, when a 3.8-magnitude quake struck roughly four miles northwest of Ohlman, according to historical tracking by NBC Chicago. Another modest 2.9-magnitude tremor registered in July, keeping geologists busy logging data across the state’s rural expanses.
Did the early morning jolt wake you up, or did you sleep right through it? Drop a comment below and share what you felt.
Related reading
- Why Cash Persists Despite India’s Digital Payment Boom
- Fatal Train Accident in Southern Poland Claims Man’s Life
- Breakthrough Salk Study Uncovers Mechanism Behind Immunotherapy Resistance: Interferons, Mitochondrial Dysfunction, and PGE2″ Interferons, mitochondrial dysfunction and PGE2: Salk study reveals mechanism behind immunotherapy resistance. Boost its search engine visibility with relevant keywords for maximum impact. Immunotherapy resistance remains one of the biggest hurdles in cancer treatment. According to a recent study published in the journal Nature Communications, scientists at the Salk Institute have made a groundbreaking discovery that sheds light on the underlying mechanisms behind this resistance. The study reveals that interferons, a type of protein that plays a crucial role in the immune system, can contribute to mitochondrial dysfunction in cancer cells. This dysfunction can lead to the production of prostaglandin E2 (PGE2), a molecule that promotes tumor growth and resistance to immunotherapy. In their study, the researchers found that PGE2 production was a key factor in the development of immunotherapy resistance in cancer cells. The team used a combination of experimental and computational models to investigate the relationship between interferons, mitochondrial dysfunction, and PGE2 production. The findings of the study suggest that targeting PGE2 production could be a potential strategy for overcoming immunotherapy resistance. The researchers propose that blocking PGE2 receptors or inhibiting its production could help restore the function of mitochondria in cancer cells, making them more susceptible to immunotherapy. The study’s authors hope that their findings will pave the way for the development of new therapies that can overcome immunotherapy resistance and improve treatment outcomes for cancer patients. Key Takeaways: – Interferons contribute to mitochondrial dysfunction in cancer cells – Mitochondrial dysfunction leads to PGE2 production, promoting tumor growth and resistance to immunotherapy – Targeting PGE2 production could be a potential strategy for overcoming immunotherapy resistance – Restoring mitochondrial function in cancer cells could make them more susceptible to immunotherapy Keywords: immunotherapy resistance, interferons, mitochondrial dysfunction, PGE2, Salk Institute, cancer treatment, breakthrough study, Nature Communications. (archyworldys.com)
- New High-Detail Map Predicts LA’s Highest-Risk Earthquake Zones (newsy-today.com)
